| STOCKHOLDERS’ EQUITY |
NOTE
11 – STOCKHOLDERS’ EQUITY
Preferred
stock
The
Company is authorized to issue 50,000,000
shares of Preferred Stock. Each share of Preferred Stock has the voting power of ten shares of Common Stock, and can at any time be
converted into five (5), shares of Common Stock. The table below sets forth the number of shares of Preferred Stock issued and
outstanding during the reporting period(s). There were 43,283,991
Preferred Stock outstanding on March 31, 2026:
Issuances
of Preferred Stock in the period January 1 and March 31, 2025
SCHEDULE OF PREFERRED STOCK ISSUED AND OUTSTANDING
| Date |
|
#
Shares | | |
Amount | | |
Price/Share | | |
Type | |
Notice | |
| 1/01/2025 |
|
| 43,158,248 | | |
$ | 4,408,582 | | |
$ | 0.102 | | |
| |
| |
| 1/10/2025 |
b |
| (150,000 | ) | |
| (750 | ) | |
| 0.005 | | |
Stock
conversion | |
affiliate | |
| 3/31/2025 |
|
| — | | |
| 214,780 | | |
| — | | |
Payroll
forfeiture* | |
affiliate | |
| See
Note 11 |
d |
| 390,140 | | |
| 131,076 | | |
| 0.342 | | |
2021
Stock Plan | |
affiliate | |
| 3/31/2025 |
|
| 43,398,388 | | |
$ | 4,753,688 | | |
$ | 0.110 | | |
| |
| |
There
has been no issuance of Preferred Stock in the period January 1 and March 31, 2026
| Date | |
#
Shares | | |
Amount | | |
Price/Share | | |
Type | |
Notice |
| 3/31/2026 | |
| 43,283,991 | | |
$ | 4,748,150 | | |
$ | 0.110 | | |
| |
|
| * |
The
transaction originating from the Company’s Officers forfeiting $578,959
of accrued payroll in the first quarter of 2025. |
Common
stock
The
Company is authorized to issue 400,000,000 shares of Common Stock. There were 113,361,886 Common Stock outstanding on March 31, 2026:
Issuances
of Common Stock in the period January 1 and March 31, 2025
SCHEDULE OF COMMON STOCK ISSUED AND OUTSTANDING
| Date |
|
#
Shares | | |
Amount | | |
Price/Share | | |
Type | |
Notice | |
| 1/01/2025 |
|
| 86,782,908 | | |
$ | 12,722,039 | | |
$ | 0.147 | | |
| |
| |
| 1/10/2025 |
b |
| 750,000 | | |
| 750 | | |
| 0.001 | | |
Stock
conversion | |
| |
| see
Note 11 |
d |
| 1,348,951 | | |
| 91,300 | | |
| 0.077 | | |
2021
Stock Plan | |
| |
| 3/31/2025 |
|
| 88,881,859 | | |
$ | 12,814,089 | | |
$ | 0.144 | | |
| |
| |
Issuances
of Common Stock in the period January 1 and March 31, 2026
| Date |
|
|
#
Shares | | |
Amount | | |
Price/Share | | |
Type | |
Notice | |
| 1/01/2026 |
|
|
| 108,147,731 | | |
$ | 13,607,433 | | |
$ | 0.126 | | |
| |
| |
| 1/23/2026 |
a |
* |
| 4,716,000 | | |
| 145,701 | | |
| 0.031 | | |
private
placement | |
| |
| 1/23/2026 |
a |
* |
| — | | |
| 95,339 | | |
| — | | |
warrants | |
| |
| 1/10/2026 |
c |
|
| 75,000 | | |
| 5,550 | | |
| 0.074 | | |
consulting
fees | |
| |
| 2/10/2026 |
c |
|
| 239,155 | | |
| 10,723 | | |
| 0.046 | | |
consulting
fees | |
| |
| 3/10/2026 |
c |
|
| 184,000 | | |
| 8,150 | | |
| 0.044 | | |
consulting
fees | |
| |
| 3/31/2026 |
|
|
| 113,361,886 | | |
$ | 13,872,896 | | |
$ | 0.122 | | |
| |
| |
Common
Shares due, but not yet issued in accordance with service contract at March 31, 2026:
| Date |
| |
# Shares | | |
Amount | | |
Price/Share | | |
Type | |
Notice |
|
| 3/31/2026 |
a | |
| 75,000 | | |
$ | 4,883 | | |
$ | 0.065 | | |
consulting fees | |
|
|
| * |
Around January 23, 2026, the Company proposed a private placement offering investors to purchase shares and warrants
issued together as a unit; however, each warrant is detachable and separately exercisable to purchase one share of Common Stock. The average
price was $0.06 per unit, less a broker (Member FINRA / SIPC) fee consisting of 8% cash commission and 8% bonus shares. The Company raised
a total of $241,040 (after $20,960 cash commission) and issued 4,716,000
shares of Common Stock (after 349,333 bonus shares), as well as 4,366,667 5-year warrants exercisable to buy Common Stock at $0.12 per
share. The net received by the Company was $0.053 per unit. |
| |
|
| a |
The
Company claims an exemption from the registration requirements of the Securities Act for the private placement of these securities
pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated under the Securities Act. |
| b |
The
Company claims an exemption from the registration requirements of the Securities Act pursuant to the exchange exemption under Rule
144 of the Securities Act. |
| c |
The
Company claims an exemption from the registration requirements of the Securities Act pursuant to the exchange exemption in Rule 3(a)(9)
of the Securities Act. |
| d |
The
Company claims an exemption from the registration requirements of the Securities Act for the compensatory benefit plan pursuant to
Rule 701 of the Securities Act. |
Common
Stock Warrants
The
fair value of Common Stock warrants granted for the three months ended March 31, 2026, and March 31, 2025 was calculated with the following
assumptions:
SCHEDULE OF STOCK WARRANTS VALUATION ASSUMPTIONS
| | |
March
31, 2026 | | |
March
31, 2025 | |
| Risk-free
interest rate | |
| 3.92 | % | |
| 3.96
– 4.61 | % |
| Expected
dividend yield | |
| 0 | % | |
| 0 | % |
| Volatility
factor (monthly) | |
| 119.99 | % | |
| 127.02 | % |
| Expected
life of warrant | |
| 5
years | | |
| 5
years | |
For
the three months ended March 31, 2026, the Company issued 4,366,667 warrants. For the three months ended March 31, 2025, the Company
did not award any warrants.
The
following table summarizes the Company’s Common Stock warrant activity for the three months ended March 31, 2026, and 2025:
SCHEDULE OF COMMON STOCK WARRANT ACTIVITY
| | | |
Number
of
Warrants
* | | |
Weighted
Average
Exercise
Price | | |
Weighted
Average
Remaining
Expected
Term | |
| Outstanding
as at January 1, 2025 | | |
| 1,292,030 | | |
$ | 0.22 | | |
| 2.6 | |
| Granted | | |
| — | | |
| — | | |
| — | |
| Exercised | | |
| — | | |
| — | | |
| — | |
| Forfeited/Cancelled | | |
| — | | |
| — | | |
| — | |
| Outstanding
as at March 31, 2025 | | |
| 1,292,030 | | |
$ | 0.22 | | |
| 2.7 | |
| | | |
| | | |
| | | |
| | |
| Outstanding
as at January 1, 2026 | | |
| 16,675,364 | | |
$ | 0.13 | | |
| 4.6 | |
| Granted | | |
| 4,366,667 | | |
| 0.12 | | |
| 5.0 | |
| Exercised | | |
| — | | |
| — | | |
| — | |
| Forfeited/Cancelled | | |
| — | | |
| — | | |
| — | |
| Outstanding
as at March 31, 2026 | | |
| 21,042,031 | | |
$ | 0.13 | | |
| 4.2 | |
The
following table summarizes information about stock warrants that are vested or expected to vest at March 31, 2026, with a market price
of $0.045 at March 31, 2026:
SCHEDULE OF WARRANT OUTSTANDING AND EXERCISABLE WARRANTS
| | | |
| | |
Warrants
Outstanding and Exercisable | | |
| |
| Exercise
Price | | |
Number
of Warrants | | |
Weighted
Average
Exercise
Price
Per
Share | | |
Weighted
Average
Remaining
Contractual
Life
(Years) | | |
Aggregate
Intrinsic
Value | |
| $ | 0.12 | | |
| 19,750,001 | | |
$ | 0.12 | | |
| 4.7 | | |
$ | — | |
| | 0.20-0.25 | | |
| 1,264,030 | | |
| 0.23 | | |
| 1.7 | | |
| — | |
| | 0.47 | | |
| 28,000 | | |
| 0.47 | | |
| 1.4 | | |
| — | |
| $ | 0.12-0.47 | | |
| 21,042,031 | | |
$ | 0.13 | | |
| 4.2 | | |
$ | — | |
The
weighted-average remaining contractual life for warrants exercisable at March 31, 2026, is 4.2 years. The aggregate intrinsic value
for fully vested, exercisable warrants was $0 at March 31, 2026.
|